Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085437 (
bacterial meningitis
)
4,038
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A case of a complicated penetrating nasal injury is presented. The rapid diagnosis of cerebrospinal fluid rhinorrhea, with appropriate bedside tests and imaging techniques, is essential for the prevention of
bacterial meningitis
.
Pediatr Emerg Care 1988
Dec
PMID:Cerebrospinal fluid rhinorrhea: a case report and review of the management. 323 57
Cerebrospinal fluid lysozyme (CSF-LZM) concentrations were determined in 62 controls, 28 viral meningitis and 22
bacterial meningitis
, as compared to CSF lactic acid routinely used. CSF-LZM measurement was performed by a rapid turbidimetric assay which required 50 microliters CSF only. The mean CSF-LZM concentration of the control group was 0.23 mg/l, the highest value being 0.65 mg/l. The mean LZM levels in viral meningitis were 1.10 mg/l, never exceeding 3 mg/l. The range of pretreatment LZM levels in
bacterial meningitis
was 7.2 to 65 mg/l and above 3 mg/l in all cases 48 h after treatment. On the 6th day after admission, 12 of 16 samples showed abnormal values. The CSF-LZM assay seems to be of more value than that of lactic acid. Thus, before treatment, LZM concentrations were 10 to 100 fold higher than that of the normal values, with persistent high levels on the 2nd and even on the 6th day of treatment (whereas lactic acid values were all normal on day 6).
Arch Fr Pediatr 1988
Dec
PMID:[Cerebrospinal fluid lysozyme in meningitis in children. Value in establishing the etiologic diagnosis]. 324 42
In this report we introduce CSF Elastase-alpha 1-Proteinase inhibitor as a valuable indicator for differentiating
bacterial meningitis
from aseptic meningitis and other neurological disorders. All patients (n = 26) with
bacterial meningitis
had increased CSF concentrations of E-alpha 1-PI above the range of normal (range of reference values: 0.0-2.3 micrograms/l, n = 79;
bacterial meningitis
: 30-3490 micrograms/l, n = 26). Concentrations of E-alpha 1-PI in
bacterial meningitis
were significantly elevated when compared with those in aseptic meningitis (0.0-194 micrograms/l, n = 37), polyneuropathy (0-23 micrograms/l, n = 24) and cerebrovascular attack (0-23.2 micrograms/l, n = 17).
Acta Neurol Scand 1988
Dec
PMID:Diagnostic value of elastase-alpha 1-proteinase inhibitor in cerebrospinal fluid. 326 64
A child who presented with cerebral herniation syndrome which was subsequently found to be a complication of
bacterial meningitis
is reported. The approach to the initial emergency department management of such a patient is discussed, as is the literature which summarizes this unusual complication.
Pediatr Emerg Care 1987
Dec
PMID:Cerebral herniation syndrome as the presenting sign of Haemophilus influenza meningitis. 332 65
Despite the apparent success of several new cephalosporins in the treatment of Gram-negative
bacterial meningitis
, four treatment failures with cefotaxime or latamoxef were encountered (two caused by Enterobacter and two by Serratia spp.) In-vitro parameters of susceptibility of these clinical isolates were compared with those of a meningeal Ent. cloacae isolate from a successfully treated patient. The MIC and MBC values, degrees of inoculum effect, and amounts of beta-lactamase produced correlated poorly with the observed clinical outcome. However, the extent to which an isolate was killed by the cephalosporin used for treatment, in a 6-h in-vitro incubation, showed good correlation. We suggest that such a test should be used to predict clinical outcome of therapy because the other parameters such as the MIC and MBC values are not sufficiently discriminatory.
J Antimicrob Chemother 1987
Dec
PMID:Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp. 350 99
Levels of C-reactive protein and lactate were determined on 562 consecutive cerebrospinal fluid (CSF) samples from adult patients with a wide variety of central nervous system diseases to compare the sensitivity and specificity of CSF lactate and C-reactive protein for the rapid diagnosis of
bacterial meningitis
. Neither test alone, together, or in combination with elevated CSF leukocyte count and protein had a predictive value over 60% for a positive test in this group of patients with diverse central nervous system problems. Neither test is useful as a screening test for bacterial or mycotic meningitis. Also, in patients with partially treated
bacterial meningitis
, the tests are often negative. CSF lactate may be useful in differentiating aseptic from septic meningitis in selected patients.
J Clin Microbiol 1986
Dec
PMID:Comparison of cerebrospinal fluid C-reactive protein and lactate for diagnosis of meningitis. 378 62
Lactate dehydrogenase activities were determined in CSF from 350 patients suffering from various neurological diseases. Reference values were established as 0-26 U/l. Slight elevations of CSF LDH activities were observed in patients with the following disorders: brain metastasis and spinal epidural metastasis from solid carcinomas, primary central nervous system tumours, cerebrovascular accident, polyneuropathy and head injury. Marked elevations were observed incidentally in patients in these groups and in a considerable number of patients with
bacterial meningitis
and with leptomeningeal spread from solid or haematologic malignancies. When other diagnostic information is available for the proper estimation of the pre-test likelihood of disease, CSF LDH activities exceeding 50 U/l are suggestive for meningeal carcinomatosis.
Clin Chim Acta 1986
Dec
30
PMID:Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases. 380 33
The penetration of imipenem and cilastatin into the cerebrospinal fluid (CSF) was determined in patients with
bacterial meningitis
. Four 1000 mg doses [corrected] of both imipenem and cilastatin were infused intravenously over 20-30 min at 6 h intervals, first between days 2 and 4, and again, whenever possible, between days 11 to 20, in 12 patients with
bacterial meningitis
undergoing treatment with other antibiotics. Concentrations of imipenem and cilastatin in serum and cerebrospinal fluid samples obtained either at 60, 90 or 120 min following the fourth dose were measured by high pressure liquid chromatography. Concentrations of imipenem in CSF ranged from 0.5 to 11 mg/1 and concentrations of cilastatin ranged from 1.1 to 10.5 mg/1, depending on the sampling time and the time elapsed since the onset of the disease.
J Antimicrob Chemother 1985
Dec
PMID:Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis. 386 60
Ceftriaxone is a new third-generation cephalosporin with excellent activity against many gram-negative, and reasonable activity against most gram-positive microorganisms. Clinical studies have demonstrated its efficacy and safety in patients with
bacterial meningitis
; respiratory tract, urinary tract, soft tissue, bone and joint infections; and gonorrhea. Ceftriaxone has been well tolerated except for diarrhea, which in most cases has not required a change in therapy. The long elimination half-life of ceftriaxone has allowed twice- and once-daily administration, the latter potentially resulting in substantial cost savings. Because of its documented efficacy, safety, and convenient dosing schedule, ceftriaxone may become the preferred third-generation cephalosporin for the treatment of a variety of serious infections.
Drug Intell Clin Pharm 1985
Dec
PMID:Ceftriaxone: a third-generation cephalosporin. 391 Mar 86
Three patients with histories of recurrent
bacterial meningitis
were previously examined with skull and sinus radiographs, routine cranial computed tomography, intrathecal radioisotope tracer studies, and immunologic evaluation. None of these studies were diagnostic. Pneumococcal vaccine and prophylactic penicillin therapy were ineffective in preventing recurrent episodes in two cases. Thin-section (2-mm) direct coronal computed cranial tomography demonstrated anatomic defects in all three patients. The use of metrizamide cisternography was not necessary to diagnose the defects. All patients had basiethmoidal encephaloceles which were repaired surgically. Direct coronal computed tomography offers a relatively easy noninvasive method for delineating anatomic abnormalities in patients with recurrent meningitis.
Pediatrics 1985
Dec
PMID:Recurrent bacterial meningitis: coronal thin-section cranial computed tomography to delineate anatomic defects. 406 65
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>